#Japan #Wakayama #Hassho Beans #L-DOPA #Kishu Hosokawa

Introducing Hassho Beans: Nature's L-DOPA Source

Kishu Hosokawa Pharma, based in Wakayama, Japan, is set to showcase its star product, the Hassho bean (native Mucuna bean), at the eagerly anticipated Food Development Expo 2025, taking place from October 15 to 17, 2025. The expo, located at Tokyo Big Sight, will exhibit cutting-edge food materials, along with functional ingredients from across the globe, attracting considerable attention from industry players.

What Are Hassho Beans?

Originating from India, Hassho beans have been utilized for centuries for their health benefits, particularly due to their high content of L-DOPA. Known as a precursor to dopamine, L-DOPA plays a crucial role in neurological health. In Japan, this bean is referred to as 'Hassho', and its name is believed to connect both to its fruitful yield and its origin on Hachijo Island.

Since 2008, Kishu Hosokawa Pharma has been at the forefront of domestic cultivation, working to revive the almost extinct local production. They now boast a robust supply system, holding over 70% market share in Japan based on their research.

Nutritional Profile of Hassho Beans

Hassho beans are not just nutrient-rich; they are exceptional compared to other legumes. They contain high levels of iron, protein, carbohydrates, fats, and various minerals. A distinguishing feature is their rich L-DOPA content, making them a highly regarded food source. Additionally, the beans provide a balanced mix of essential amino acids, as well as non-essential amino acids like glycine.

Commitment to Quality and Supply Security

Leading Market Share

With over 70% domestic sell-through of Mucuna bean products, Kishu Hosokawa Pharma leads the industry, ensuring that their clients receive the best quality Hassho beans. Their commitment to reviving and cultivating these beans in the Kishu region has resulted in a supply system that is the largest in Japan.

Stable Supply System

Around 80% of the beans offered are cultivated on their own farms, with the remaining sourced from trusted partners across Wakayama, Shiga, and Kumamoto prefectures. This level of control over their supply chain grants Kishu Hosokawa Pharma a competitive edge in ensuring product availability.

Safety Protocols

Kishu Hosokawa Pharma prioritizes safety. Their Hassho beans have undergone rigorous pesticide testing, with all results showing no trace of harmful residues. This thorough process adds another layer of trust for consumers and manufacturers seeking high-quality raw materials.

Collaborative Research

Kishu Hosokawa Pharma is also engaged in academic partnerships, including research with Ehime University. This collaboration has led to published studies, showcasing the scientific backing of their products—a significant advantage in today’s health-conscious market.

Visit Us at Food Development Expo 2025

The upcoming Food Development Expo 2025 marks a significant event for Kishu Hosokawa Pharma. Attendees are encouraged to register online to experience the latest in functional food materials. The Kishu Hosokawa Pharma booth (4-166) will offer insights into Hassho beans, including samples of the raw ingredients in various forms, such as powders and roasted beans, alongside information on OEM development and supplement creation.

Event Details:

• - Date: October 15-17, 2025
• - Location: Tokyo Big Sight, Halls & Atrium 1, 2, and 4
• - Hosted by: Informa Markets Japan
• - Pre-registration Required: Free registration is available and recommended for smooth access.
• - Event Registration Link

Conclusion

With a focus on sustainability, health, and cutting-edge research, Kishu Hosokawa Pharma is setting new standards in the industry through their dedication to Hassho beans. As more consumers and manufacturers recognize the benefits of natural ingredients such as these, the future of food development looks promising. Join them at the expo and discover the possibilities that Hassho beans can offer in enhancing health through culinary innovation.